JP2017510638A - アサ属抽出方法及び組成物 - Google Patents
アサ属抽出方法及び組成物 Download PDFInfo
- Publication number
- JP2017510638A JP2017510638A JP2017501067A JP2017501067A JP2017510638A JP 2017510638 A JP2017510638 A JP 2017510638A JP 2017501067 A JP2017501067 A JP 2017501067A JP 2017501067 A JP2017501067 A JP 2017501067A JP 2017510638 A JP2017510638 A JP 2017510638A
- Authority
- JP
- Japan
- Prior art keywords
- asa
- skin
- aloe
- plant material
- aloe extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000000605 extraction Methods 0.000 title claims description 32
- 241000196324 Embryophyta Species 0.000 claims abstract description 40
- 239000000463 material Substances 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 29
- 229940069521 aloe extract Drugs 0.000 claims abstract description 27
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 22
- 241001116389 Aloe Species 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 21
- 239000008194 pharmaceutical composition Substances 0.000 claims description 20
- 239000002537 cosmetic Substances 0.000 claims description 16
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 208000000453 Skin Neoplasms Diseases 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 7
- 240000004308 marijuana Species 0.000 claims description 7
- 201000000849 skin cancer Diseases 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- 244000025254 Cannabis sativa Species 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 235000008697 Cannabis sativa Nutrition 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 3
- 201000004624 Dermatitis Diseases 0.000 claims description 3
- 206010000496 acne Diseases 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- 238000010908 decantation Methods 0.000 claims description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 claims description 2
- 206010063409 Acarodermatitis Diseases 0.000 claims description 2
- 206010008570 Chloasma Diseases 0.000 claims description 2
- 206010013786 Dry skin Diseases 0.000 claims description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims description 2
- 208000003351 Melanosis Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 241000447727 Scabies Species 0.000 claims description 2
- 206010042496 Sunburn Diseases 0.000 claims description 2
- 208000002474 Tinea Diseases 0.000 claims description 2
- 240000008042 Zea mays Species 0.000 claims description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 2
- 206010000269 abscess Diseases 0.000 claims description 2
- 208000009621 actinic keratosis Diseases 0.000 claims description 2
- 230000032683 aging Effects 0.000 claims description 2
- 244000213578 camo Species 0.000 claims description 2
- 235000009120 camo Nutrition 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 235000005607 chanvre indien Nutrition 0.000 claims description 2
- 235000005822 corn Nutrition 0.000 claims description 2
- 230000037336 dry skin Effects 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229960004592 isopropanol Drugs 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 201000001441 melanoma Diseases 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 208000005687 scabies Diseases 0.000 claims description 2
- 201000000195 skin tag Diseases 0.000 claims description 2
- 241000894007 species Species 0.000 claims description 2
- 241000218236 Cannabis Species 0.000 claims 1
- 206010063562 Radiation skin injury Diseases 0.000 claims 1
- 241000130764 Tinea Species 0.000 claims 1
- 208000000260 Warts Diseases 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 201000010153 skin papilloma Diseases 0.000 claims 1
- 230000000699 topical effect Effects 0.000 abstract description 5
- 229930003827 cannabinoid Natural products 0.000 description 19
- 239000003557 cannabinoid Substances 0.000 description 19
- 229940065144 cannabinoids Drugs 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 7
- 239000002674 ointment Substances 0.000 description 7
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 5
- -1 cannabinol Chemical compound 0.000 description 5
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000011149 active material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 244000144927 Aloe barbadensis Species 0.000 description 3
- 235000002961 Aloe barbadensis Nutrition 0.000 description 3
- VBGLYOIFKLUMQG-UHFFFAOYSA-N Cannabinol Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCCCC)C=C3OC(C)(C)C2=C1 VBGLYOIFKLUMQG-UHFFFAOYSA-N 0.000 description 3
- 229960003453 cannabinol Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 2
- 229950011318 cannabidiol Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- RJBSTXIIQYFNPX-UHFFFAOYSA-N 4-methoxy-6-phenyl-1,3,5-triazin-2-amine Chemical compound COC1=NC(N)=NC(C=2C=CC=CC=2)=N1 RJBSTXIIQYFNPX-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 240000007474 Aloe arborescens Species 0.000 description 1
- 235000004509 Aloe arborescens Nutrition 0.000 description 1
- 241000230099 Aloe nyeriensis Species 0.000 description 1
- 241000778028 Aloidendron dichotomum Species 0.000 description 1
- 241001531759 Aristaloe aristata Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000187664 Nerium oleander Species 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Norphytane Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- UULYVBBLIYLRCU-UHFFFAOYSA-N Palmitinsaeure-n-tetradecylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC UULYVBBLIYLRCU-UHFFFAOYSA-N 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 1
- 241001116498 Taxus baccata Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 229940008102 alloin Drugs 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- AFHJQYHRLPMKHU-CGISPIQUSA-N aloin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-CGISPIQUSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 1
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- HCAWPGARWVBULJ-IAGOWNOFSA-N delta8-THC Chemical compound C1C(C)=CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 HCAWPGARWVBULJ-IAGOWNOFSA-N 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960004242 dronabinol Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000011499 joint compound Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- SLLMDHBKALJDBW-UHFFFAOYSA-N methyl 3-(4-hydroxyphenyl)-2-(phenylmethoxycarbonylamino)propanoate Chemical compound C=1C=CC=CC=1COC(=O)NC(C(=O)OC)CC1=CC=C(O)C=C1 SLLMDHBKALJDBW-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940016409 methylsulfonylmethane Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229950009195 phenylpropanol Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
本出願は、2014年3月21日に出願された米国仮特許出願第61/968,893号に基づく優先権を主張し、この内容は、参照により本明細書中に組み込まれる。
特に指定しない限り、技術用語は、グローヒル科学技術用語大辞典(McGraw‐Hill Dictionary of Scientific and Technical Terms)(第6版)において、特定された意味を有する。
本発明の方法において、アサ属植物材料は、アロエを含む、本質的にアロエからなる、又はアロエからなる、抽出剤と組み合わせて、アサ属アロエ抽出物を形成する。
上記のように得られたアサ属アロエ抽出物は、アサ属アロエ抽出物、及び少なくとも1つの医薬的に許容される担体を含む、医薬組成物のための主成分を提供する。他の実施態様では、アサ属アロエ抽出物、及び少なくとも1つの皮膚剤を含む、化粧品組成物を提供する。
本出願は、有効な量の本発明の医薬組成物を、対象の皮膚に適用することを含む、皮膚の状態(上記に定義した通り)を治療するか、又はさもなければ、改善する方法を開示する。この文脈において、皮膚の状態を治療することは、必ずしも、治療(medical treatment)を意味するものではなく、そして従って、例えば、化粧品の適用に典型的に関連する利益、例えば、皮膚の状態を整えること、皮膚を軟化させること、又は保湿すること、皮膚の色調調整、及び引締めを容易にすること、毛穴の大きさを縮小すること、しみ、にきび、しわ、及び/又は毛の出現を低減することを提供すること含んでもよい。
本発明のさらなる実施態様では、アサ属アロエ抽出物、又は医薬組成物と共に使用される塗布器を提供し、ここで、塗布器は、抽出物、又は医薬組成物を含み、そして対象の皮膚にそれを適用するために使用される。塗布器は、手動ポンプ、エアロゾル缶、パッチ、又は回転塗布式(roll‐on)装置、例えば、デオドラントの適用のために使用されるものの形態をとることができる。
大麻(Cannabis sativa)の乾燥葉及び茎(100g)を、微粉末に粉砕し、ガラス容器に秤量し、そして、0.1%のソルビン酸カリウムを含む、pH3.7〜4.1の最大量のアントラキノン(アロイン及び/又はアロエエモジン)(1ppm)を有する液体に処理された、アロエバルバデンシス葉汁由来のアロエ(900g)と混合した。
実施例1に記載のように調製した抽出物(実質的に植物材料残渣を含まない)を、医薬組成物の全量ベースで、皮膚剤と、4重量部の抽出物:1重量部の皮膚剤の比率で、組み合わせた。皮膚剤は、グリセリン、メチルスルホニルメタン、コメ(Oryzo Sativa)(ライスブラン)油、トウゴマ(キャスター)油、ステアリン酸グリセリル、スチレン/アクリル酸コポリマー、ステアリン酸PEG‐100、セチルアルコール、ジメチコーン、カルボマー、カプリリル グリコール、グリセリン、カプリル酸グリセリル、フェニルプロパノール、メチルパラベン、トコフェロール(ビタミンE)、及び香料を含む。
Claims (18)
- アサ属植物材料と、アロエを含む抽出剤を混合し、アサ属アロエ抽出物を形成させることを含む、アサ属アロエ抽出物の調製方法。
- アサ属アロエ抽出物から、アサ属植物材料を分離し、実質的にアサ属植物材料を含まないアサ属アロエ抽出物を回収することをさらに含む、請求項1に記載の方法。
- 前記アサ属植物材料が、大麻(Cannabis sativa)、カンナビス インディカ(Cannabis indica)、及びカンナビス ルデラリス(Cannabis ruderalis)からなる群から選択される種に由来する、請求項1に記載の方法。
- 前記アサ属植物材料が、大麻(Cannabis sativa)に由来する、請求項1に記載の方法。
- 約1重量部〜約50重量部のアサ属植物材料が、約1重量部〜約100重量部のアロエと混合される、請求項1に記載の方法。
- 抽出混合物が、任意により、アルコール、ケトン、及びエステルからなる群から選択される少なくとも1つの追加の抽出剤をさらに含む、請求項1に記載の方法。
- 前記追加の抽出剤が、メタノール、エタノール、プロパノール、n‐及びイソ‐プロパノール、n‐ブタノール、tert‐ブタノール、アセトン、メチルエチルケトン、メトキシエタノール、2‐ブトキシエタノール、ジエチルエーテル、アセトン、ブタノン、酢酸エチル、並びにそれらの混合物からなる群から選択される、請求項6に記載の方法。
- 前記分離方法が、濾過、遠心分離、及びデカンテーションからなる群から選択されるか、又はそれらの組み合わせである、請求項1に記載の方法。
- 前記混合物を、約25℃〜約100℃で、約1時間〜約10時間の間、加熱することをさらに含む、請求項1に記載の方法。
- 請求項1に記載の方法により調製されたアサ属アロエ抽出物。
- 請求項10に記載のアサ属アロエ抽出物、及び少なくとも1つの医薬的に許容される担体を含む、医薬組成物。
- 請求項10に記載のアサ属アロエ抽出物、及び少なくとも1つの皮膚剤を含む、化粧品組成物。
- 請求項11に記載の医薬組成物の有効量を、患者の皮膚に適用することを含む、それを必要とする患者における皮膚の状態の治療方法。
- 前記皮膚の状態が、膿瘍、乾燥肌、日焼けで傷んだ皮膚、老化肌、にきび、光線角化症、しみ、肝斑、火傷、日焼け、熱傷、放射線による火傷、ヘルペス、うおのめ、皮膚炎、乾癬、白癬、疥癬、皮膚癌、基底皮膚癌、扁平皮膚癌、黒色腫、軟性線維腫、及びいぼからなる群から選択される、請求項13に記載の方法。
- 化粧品適用を必要とする対象を特定し、そして請求項12に記載の化粧品組成物の美容上有効な量を適用することを含む、皮膚を美容的に治療する方法。
- 請求項10に記載のアサ属アロエ抽出物を含む、塗布装置。
- 前記塗布装置が、手動ポンプ、エアロゾル缶、パッチ、及び回転塗布式装置からなる群から選択される、請求項16に記載の塗布装置。
- 請求項12に記載の化粧品組成物を含む、塗布装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461968893P | 2014-03-21 | 2014-03-21 | |
US61/968,893 | 2014-03-21 | ||
PCT/US2015/019699 WO2015142574A1 (en) | 2014-03-21 | 2015-03-10 | Cannabis extraction method and compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017510638A true JP2017510638A (ja) | 2017-04-13 |
JP6673895B2 JP6673895B2 (ja) | 2020-03-25 |
Family
ID=54145148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017501067A Active JP6673895B2 (ja) | 2014-03-21 | 2015-03-10 | アサ属抽出方法及び組成物 |
Country Status (5)
Country | Link |
---|---|
US (2) | US10307446B2 (ja) |
JP (1) | JP6673895B2 (ja) |
CN (1) | CN106232130A (ja) |
HK (1) | HK1232149A1 (ja) |
WO (1) | WO2015142574A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019530655A (ja) * | 2016-09-05 | 2019-10-24 | ラボラトワール クラランス | アルブツス・ウネドの果実抽出物の化粧品としての使用 |
KR20200064942A (ko) * | 2018-11-29 | 2020-06-08 | 주식회사 그린러쉬 농업회사법인 | 노화방지용 화장료 조성물 |
WO2022131394A1 (ko) * | 2020-12-16 | 2022-06-23 | 주식회사 애드홈 | 칸나비디올 오일을 이용한 식물성 오일 에멀젼의 제조방법 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
US10272360B2 (en) | 2017-08-05 | 2019-04-30 | Priya Naturals, Inc. | Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto |
CN107349157A (zh) * | 2017-09-06 | 2017-11-17 | 云南汉木森生物科技有限责任公司 | 含火麻叶提取物的祛斑抗皱雪花膏及其制备方法 |
CN107811904B (zh) * | 2017-10-27 | 2020-07-14 | 云南汉木森生物科技有限责任公司 | 抗炎祛斑雪花膏及其制备方法 |
KR20200108015A (ko) * | 2018-01-10 | 2020-09-16 | 브라이트씨드, 인크. | 대사를 조절하기 위한 방법 |
EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
US10570350B1 (en) | 2018-08-17 | 2020-02-25 | Evello International, LLC | Systems and methods of cannabis oil extraction |
US10688410B2 (en) | 2018-08-17 | 2020-06-23 | Evello International, LLC | Systems and methods of cannabis oil extraction |
CA3119729A1 (en) | 2018-10-10 | 2020-04-16 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
US10512856B1 (en) | 2019-01-11 | 2019-12-24 | Gildrien Farm, LLC | Method of extracting one or more chemical extracts from a plant product |
US10799812B2 (en) | 2019-01-11 | 2020-10-13 | Gildrien Farm, LLC | Method of extracting one or more chemical extracts from a plant product |
CN111000764A (zh) * | 2019-10-30 | 2020-04-14 | 广州市浪奇实业股份有限公司 | 一种抗菌皮肤清洁用品 |
AU2020427201A1 (en) * | 2020-02-07 | 2022-08-25 | Desert Harvest, Inc. | Novel cannabinoid carrier compositions having enhance pharmacokinetic properties and methods of use thereof |
WO2023283626A1 (en) * | 2021-07-09 | 2023-01-12 | TAAC Naturals, LLC | Enhanced cannabinoid compositions and methods for making same |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002275079A (ja) * | 2001-03-15 | 2002-09-25 | Fancl Corp | グルタチオン増強用組成物 |
JP2004107286A (ja) * | 2002-09-20 | 2004-04-08 | Ichimaru Pharcos Co Ltd | 化粧料組成物及び美容・健康食品組成物 |
JP2004511517A (ja) * | 2000-10-17 | 2004-04-15 | デルタ−9−ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング | カンナビス植物材料からテトラヒドロカンナビノールとカンナビジオールとを含有する抽出物を製造する方法並びにカンナビス抽出物 |
JP2006511456A (ja) * | 2002-08-14 | 2006-04-06 | ジーダブリュー ファーマ リミテッド | 植物材料からの薬学的に活性な成分の抽出の改良 |
JP2010059161A (ja) * | 2008-09-05 | 2010-03-18 | Lvmh Recherche | 精油の混合物を含む化粧用又は皮膚科用組成物、及び特に敏感肌又は感作肌のケアのためのその使用 |
JP2012505894A (ja) * | 2008-10-14 | 2012-03-08 | ネリウム バイオテクノロジー、インク. | 強心配糖体抽出プロセスおよび組成物 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4957907A (en) | 1985-06-28 | 1990-09-18 | Carrington Laboratories Inc. | Process for preparation of aloe products |
US5747352A (en) | 1994-05-23 | 1998-05-05 | Beckman Instruments, Inc. | Reagents and methods for the rapid and quantitative assay of pharmacological agents |
US5910419A (en) | 1997-05-06 | 1999-06-08 | Johnson; Ted Donald | Method for forensically screening hair samples for the presence of cannabinoids |
US6730519B2 (en) | 1998-10-26 | 2004-05-04 | The University Of Mississippi | Method of preparing delta-9-tetrahydrocannabinol |
EP1125132A1 (en) | 1998-10-30 | 2001-08-22 | Merska B.V. | Screening for analytes using labeled receptors |
IL151603A0 (en) | 2000-03-09 | 2003-04-10 | Gw Pharma Ltd | A pharmaceutical composition containing cannabis and devices for delivering the same |
GB2377218A (en) | 2001-05-04 | 2003-01-08 | Gw Pharmaceuticals Ltd | Process and apparatus for extraction of active substances and enriched extracts from natural products |
US20030017216A1 (en) | 2001-07-23 | 2003-01-23 | Schmidt Robert Gustav | Isolation of herbal and cannabinoid medicinal extracts |
US7344736B2 (en) | 2002-08-14 | 2008-03-18 | Gw Pharma Limited | Extraction of pharmaceutically active components from plant materials |
US6946150B2 (en) | 2002-08-14 | 2005-09-20 | Gw Pharma Limited | Pharmaceutical formulation |
FI20022048A0 (fi) | 2002-11-18 | 2002-11-18 | Valtion Teknillinen | Ei-kompetetiivinen immunomääritys pienille analyyteille |
GB2414933B (en) | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
AU2005305675B2 (en) | 2004-11-16 | 2012-12-13 | Gw Pharma Limited | New use for cannabinoid |
US20080103193A1 (en) | 2006-10-26 | 2008-05-01 | Trevor Percival Castor | Methods for making compositions and compositions for treating pain and cachexia |
GB2448535A (en) | 2007-04-19 | 2008-10-22 | Gw Pharma Ltd | New use for cannabinoid-containing plant extracts |
DE102007046086A1 (de) | 2007-09-26 | 2009-04-09 | Heinz Prof. Dr. Letzel | Pflanzenextrakt aus THC-armen Cannabis zur Behandlung von Erkrankungen |
FI20085579A0 (fi) | 2008-06-12 | 2008-06-12 | Valtion Teknillinen | Kannabiskäytön toteaminen |
US9066910B2 (en) | 2010-04-15 | 2015-06-30 | Steven Rosenblatt | Methods and compositions of cannabis extracts |
US20120264818A1 (en) | 2011-04-15 | 2012-10-18 | Jon Newland | Topical Compositions with Cannabis Extracts |
US8343553B2 (en) | 2011-04-18 | 2013-01-01 | Hospodor Andrew D | Essential element extractor |
CN104010662B (zh) * | 2011-08-16 | 2016-12-21 | 凯诗薇有限责任公司 | 使皮肤回春的组合物和方法 |
US20130079531A1 (en) | 2011-09-27 | 2013-03-28 | Rm3 Labs LLC | Process for the Rapid Extraction of Active Ingredients from Herbal Materials |
US9358259B2 (en) | 2012-03-20 | 2016-06-07 | Andrew David Hospodor | Recycling cannabinoid extractor |
CN102698045A (zh) * | 2012-06-21 | 2012-10-03 | 武汉长江巨龙药业有限公司 | 一种治疗产后便秘的中药制剂 |
US9333229B2 (en) | 2013-10-16 | 2016-05-10 | William Bjorncrantz | Winterized crude cannabis extracts and methods of preparation and use |
-
2015
- 2015-03-10 JP JP2017501067A patent/JP6673895B2/ja active Active
- 2015-03-10 WO PCT/US2015/019699 patent/WO2015142574A1/en active Application Filing
- 2015-03-10 US US15/037,817 patent/US10307446B2/en active Active
- 2015-03-10 CN CN201580020633.1A patent/CN106232130A/zh active Pending
-
2017
- 2017-06-14 HK HK17105888.5A patent/HK1232149A1/zh unknown
-
2019
- 2019-04-12 US US16/382,629 patent/US10646526B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004511517A (ja) * | 2000-10-17 | 2004-04-15 | デルタ−9−ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング | カンナビス植物材料からテトラヒドロカンナビノールとカンナビジオールとを含有する抽出物を製造する方法並びにカンナビス抽出物 |
JP2002275079A (ja) * | 2001-03-15 | 2002-09-25 | Fancl Corp | グルタチオン増強用組成物 |
JP2006511456A (ja) * | 2002-08-14 | 2006-04-06 | ジーダブリュー ファーマ リミテッド | 植物材料からの薬学的に活性な成分の抽出の改良 |
JP2004107286A (ja) * | 2002-09-20 | 2004-04-08 | Ichimaru Pharcos Co Ltd | 化粧料組成物及び美容・健康食品組成物 |
JP2010059161A (ja) * | 2008-09-05 | 2010-03-18 | Lvmh Recherche | 精油の混合物を含む化粧用又は皮膚科用組成物、及び特に敏感肌又は感作肌のケアのためのその使用 |
JP2012505894A (ja) * | 2008-10-14 | 2012-03-08 | ネリウム バイオテクノロジー、インク. | 強心配糖体抽出プロセスおよび組成物 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019530655A (ja) * | 2016-09-05 | 2019-10-24 | ラボラトワール クラランス | アルブツス・ウネドの果実抽出物の化粧品としての使用 |
KR20200064942A (ko) * | 2018-11-29 | 2020-06-08 | 주식회사 그린러쉬 농업회사법인 | 노화방지용 화장료 조성물 |
KR102205205B1 (ko) * | 2018-11-29 | 2021-01-20 | 주식회사 그린러쉬 농업회사법인 | 노화방지용 화장료 조성물 |
WO2022131394A1 (ko) * | 2020-12-16 | 2022-06-23 | 주식회사 애드홈 | 칸나비디올 오일을 이용한 식물성 오일 에멀젼의 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
CN106232130A (zh) | 2016-12-14 |
US20190240272A1 (en) | 2019-08-08 |
JP6673895B2 (ja) | 2020-03-25 |
US10307446B2 (en) | 2019-06-04 |
US20160287652A1 (en) | 2016-10-06 |
US10646526B2 (en) | 2020-05-12 |
HK1232149A1 (zh) | 2018-01-05 |
WO2015142574A1 (en) | 2015-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10646526B2 (en) | Cannabis extraction method and compositions | |
Pawar et al. | Phytosome as a novel biomedicine: a microencapsulated drug delivery system | |
US8524286B2 (en) | Plant extraction method and compositions | |
EP2030626B1 (en) | Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds | |
MX2007005886A (es) | Composiciones farmaceuticas y terapeuticas derivadas de la planta garcinia mangostana l. | |
US20210322338A1 (en) | Compositions comprising cbd for treating dermatological conditions | |
TW201642849A (zh) | 包括芝麻素之組成物、其製造方法及用於皮膚抗老化及皮膚美白應用之用途 | |
JP2011519872A (ja) | 梅エキス及びその製造方法と使用 | |
CN106265792B (zh) | 一种抗皮肤光老化的药物及其检测方法 | |
KR102045946B1 (ko) | 아실화된 사포닌을 유효성분으로 포함하는 항염 화장료 조성물 또는 항염 피부 외용제 | |
KR101184313B1 (ko) | 항염증 활성을 갖는 천연화장료 이로미스 No.4 콤플렉스 | |
JP6267412B2 (ja) | cAMP産生抑制剤 | |
KR20030073995A (ko) | 항염, 항자극 효과가 있는 복령 추출물을 함유하는 화장료조성물과 그의 제조방법 | |
Shah et al. | POLY HERBAL SKIN CLARIFYING AND UV PROTECTION CREAM | |
Eid et al. | Phytochemical and Biological Evaluation of a Newly Designed Vitis Vinifera Seed Oil Self-Nanoemulsifying System | |
Tasnim et al. | Exploration of analgesic, laxative and immunomodulatory effects of leaves and twigs of Euphorbia tirucalli along with in silico analysis | |
KR20230057788A (ko) | 멍 완화 또는 제거용 조성물 | |
JP2024049127A (ja) | 肌のくすみ改善剤 | |
JP2022532559A (ja) | 汚染防止物質としてのアグリモニー抽出物 | |
KR20200145026A (ko) | 문관과유실수를 함유하는 기능성 화장료 조성물과 그 제조방법 | |
KR20210009755A (ko) | 기름밤나무 유실수를 포함하는 기능성 조성물과 그 제조방법 | |
BR102016013555A2 (pt) | Pharmaceutical and pharmaceutical composition composition composition for composition, composition, pharmaceutical and pharmaceutical treatment composition, pharmaceutical method for the application of the same and use of the composition or product for medical and aesthetic treatments | |
ROGANOVIĆ et al. | POSSIBILITIES AND ADVANTAGES IN THE APPLICATION OF SUPERCRITICAL EXTRACTS AS ACTIVE INGREDIENTS IN COSMETIC PRODUCTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180305 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190320 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190507 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190806 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190909 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200204 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200305 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6673895 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |